Cromos Pharma celebrates Cancer Survivors Month
The number of cancer survivors is rising worldwide, due to advances in early detection and treatment as well as the aging of the world’s population. In 2018, there were approximately 43.8 million cancer survivors diagnosed within the previous 5 years. This June Cromos Pharma is celebrating #CancerSurvivorMonth by remembering all those who are currently going through their cancer journey
Cromos Pharma at BIO Digital 14 – 18 June
Are you attending #BIODigital 14 – 18 June? Cromos Pharma is delighted to be taking part this week. Connect with us to discuss your clinical trial needs. To set up a meeting please follow this link for partnering>> If you can’t make it this week, email us at bd@cromospharma.com to arrange a call at your convenience to discuss your next clinical research project.
FDA approves first new Alzheimer’s drug in 20 years
June is Alzheimer’s and Brain Awareness Month. Alzheimer’s Disease is a form of dementia – a syndrome characterized by deterioration in memory, thinking, behavior and ability to do everyday tasks. Dementia affects 50 million people worldwide with 10 million cases being diagnosed each year. Alzheimer’s Disease (AD) is the most common form of dementia making up
